Loading
AB
Array Biopharma Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 22 Jan 2016.
Array Biopharma Inc: what insiders have been doing
This page follows insider dealings at Array Biopharma Inc as filed with SEC (Form 4). Array Biopharma Inc has had no insider filing for more than a year; the last one goes back to 22 January 2016.
Our records for Array Biopharma Inc go back to 2016, with 8 purchases and no sales on the open market in total.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
8 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2018FY ended June 2018 · cache
Income statement
Net income-131.4M
Last declaration on 22 January 2016
Declarations8 total
300,000 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009564:0
Canonical exit: 19 Apr 2016 (T+90)
75,000 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009285:0
Canonical exit: 11 Apr 2016 (T+90)
300,000 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009138:0
Canonical exit: 6 Apr 2016 (T+90)
350,000 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009138:1
Canonical exit: 7 Apr 2016 (T+90)
275,000 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009138:2
Canonical exit: 10 Apr 2016 (T+90)
317,548 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009136:0
Canonical exit: 28 Dec 2015 (T+90)
182,452 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009136:1
Canonical exit: 29 Dec 2015 (T+90)
100,140 sharesCommon stock, $0.001 par valueSEC:0000919574-16-009136:2
Canonical exit: 30 Dec 2015 (T+90)
8 of 8 declarations
About Array Biopharma Inc
Array Biopharma Inc is a biopharmaceutical company focused on developing treatments for cancer. It is listed on NASDAQ under the ticker ARRY.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
